SENSEX
NIFTY
GOLD
USD/INR

Weather

image 17    C

Science & Environment News

The Economic Times

Science & Environment / The Economic Times

details

Mankind Pharma shares key business developments from Q2 & H1 of FY27

The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of 18.7% and 15.8%, respectively. In acute therapies, gastroenterology grew at 1.3 times the market rate, while vitamins, minerals and nutrients (VMN) expanded at 1.4 times that rate.

26 Oct 2026 5:48 pm